# Oxytocin Aging Study

> **NCT02069431** · PHASE1 · TERMINATED · sponsor: **University of Florida** · enrollment: 153 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** Intranasal Oxytocin spray
- **OTHER:** Intranasal Placebo spray

## Key facts

- **NCT ID:** NCT02069431
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 153 (ACTUAL)
- **Why stopped:** This study was halted prematurely due to the COVID-19 pandemic, resulting in the inability to enroll participants. Funding for this project has also ended.
- **Last updated:** 2020-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02069431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02069431, "Oxytocin Aging Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02069431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*